SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-065593
Filing Date
2021-05-13
Accepted
2021-05-13 09:30:10
Documents
3
Period of Report
2021-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2116118d1_8k.htm 8-K 18968
2 EXHIBIT 99.1 tm2116118d1_ex99-1.htm EX-99.1 22187
3 GRAPHIC tm2116118d1_ex99-1img01.jpg GRAPHIC 5478
  Complete submission text file 0001104659-21-065593.txt   50169
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38807 | Film No.: 21917593
SIC: 2834 Pharmaceutical Preparations